Nutrigenomics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Reagents, Kits, and Services), Sample Type (Saliva, Buccal Swab, and Blood), By Application (Diabetes, Obesity, Gastrointestinal, Women’s Health, Neurological, and Others), By End User (Online Platform, hospitals, Clinics, and Others), and Region Forecast 2020-2031

Nutrigenomics Market size was valued at US$ 543.22 million in 2024 and is expected to reach US$ 1659.81 million by 2031, growing at a significant CAGR of 17.3% from 2025-2031. The rising incidence of obesity is one of the key market driver projected to boost the market growth during the forecast period. The significance of nutritious food among preventative measures for malnutrition, multiple cardiovascular diseases, obesity, and related disorders is also anticipated to drive the growth of the nutrigenomics industry. Globally, the increasing cancer incidence rates are predicted to drive market development. A better understanding of the genetic component of both wellness and illness, among effective therapeutic interventions to help with disease diagnosis, are two additional benefits of nutrigenomics.

Furthermore, understanding the molecular interactions between nutrients and the genome is the main goal of nutrigenomics, which aims to know how different nutrients and dietary patterns can impact human health. It is projected that nutrigenomics would strongly care for the newly developed therapeutic techniques. Nutrigenomics services have developed as a result of growth in the genomics research. Thus, it is predicted that the market will be driven by the rising application of nutrition within the target demographic and several advantages, such as a focus on illness prevention and reducing the indications of aging which subsequently aid in the expansion of the market. Moreover, the rapid acceptance of genomics and personalized medicine, the rising prevalence of lifestyle diseases like obesity and diabetes, rising awareness of preventative healthcare, and different beneficial pricing strategies employed by market players are some of the favourable factors likely to drive the growth of the market.

Key Developments:

• In June 2023, Xcode initiated a wide-ranging gene nutrition test along with various aspects of nutrients.  
• In June 2018, 23&Me made a partnership with GlaxoSmithKline to work on new treatments and possible therapies using human genetics as a foundation for exploration.
• In February 2018, The Global Genetic Project was initiated by 23&Me to enhance understanding of human genetic variety and deliver insights into health concerns that may affect understated populations in genetic research.
• In June 2017, DNAFit agreed with Vita Mojo to produce the world's most personalized restaurant menu, designed to each customer's DNA.